Predictboard ·
🎯 Other
Will the FDA approve retatrutide?

Will the FDA approve retatrutide? — Before Jul 1, 2027

Live
Resolves Jul 1, 2027Kalshi
Volume-weighted avg
24%
No
76%
No (76%)Yes (24%)
Check on Kalshi →
Probability History
Loading...
Market snapshot
Status
Open
Category
Other
Vol 24h
—
Liquidity
$7k

Market intelligence

Kalshi currently prices this at 24%. Kalshi has moved down 19pp over the past 7 days.

About this market

If the FDA approves retatrutide (LY3437943) for marketing before Jul 1, 2027, then the market resolves to Yes.

All outcomes · Will the FDA approve retatrutide?

Will the FDA approve retatrutide? — Before Jan 1, 2029
92%
Will the FDA approve retatrutide? — Before Jul 1, 2028
88%
Will the FDA approve retatrutide? — Before Jan 1, 2028
84%
Will the FDA approve retatrutide? — Before Jan 1, 2027
7%
Trade this marketLive prices
Avg probability
24%
probability of YES
Kalshi
24%Check
TGWA
Create Widget
Resolution
Jul 1, 2027
Market is open
Market stats
24h volume—
Liquidity$7k
CategoryOther
StatusOpen